The Diagnosis Of Multiple Sclerosis DR SAHER HASHEM PROF OF NEUROLOGY CAIRO UNIVERSITY

Similar documents
MRI in Differential Diagnosis. CMSC, June 2, Jill Conway, MD, MA, MSCE

MRI and differential diagnosis in patients suspected of having MS

New Insights on Optic Neuritis in Young People

Myelitis. Case 2. History. Examination. Mahtab Ghadiri

Actualização no diagnóstico e tratamento das doenças desmielinizantes na infância. Silvia Tenembaum

Title: Recurrent myelitis after allogeneic stem cell transplantation. Report of two cases.

PMH: No medications; Immunizations UTD No hospitalizations or surgeries Speech Delay. Birth Hx: 24 WGA, NICU x6 months

Patologie infiammatorie encefaliche e midollari

Pediatric acute demyelinating encephalomyelitis in Denmark: a nationwide population-based study

Tony Traboulsee, MD Associate Professor (Medicine/Neurology) Head, UBC MS and NMO Programs. MRI Diagnostic Red Flags

Interactive Cases: Demyelinating Diseases and Mimics. Disclosures. Case 1 25 yo F with nystagmus; look for tumor 4/14/2017

MYELITIS. A Mochan Neurology

Disease of Myelin. Reid R. Heffner, MD Distinguished Teaching Professor Emeritus Department of Pathology and Anatomy January 9, 2019

Clinical Case Study Discussion of Demyelinating Diseases. Mirela Cerghet, MD, PhD Henry Ford Hospital August 6, 2011

1st interactive course in MS advanced managment

MULTIPLE SCLEROSIS Update

Vague Neurological Conditions

COPYRIGHT 2012 THE TRANSVERSE MYELITIS ASSOCIATION. ALL RIGHTS RESERVED

Clinical and research application of MRI in diagnosis and monitoring of multiple sclerosis

Seema Sikka, MD January 18, 2014 TRANSVERSE MYELITIS: A CLINICAL OVERVIEW

Idiopathic Inflammatory Demyelinating Diseases of the Brainstem

Difficult Diagnosis: Case History. 7 months prior, she happened to have undergone a C-spine MRI after a car accident

CHAIR SUMMIT 7TH ANNUAL #CHAIR2014. Master Class for Neuroscience Professional Development. September 11 13, Westin Tampa Harbour Island

Magnetic Resonance Imaging of Neuromyelitis Optica (Devic s Syndrome)

Demyelinating Diseases: Multiple Sclerosis January 10, 2018 Dr. Ostrow

Demyelinating Diseases of the Brain

Role of MRI in acute disseminated encephalomyelitis

Neuromyelitis optica (NMO), or Devic s disease, is a rare

Wingerchuk et al, Neurol, 2006

Heterogeneity of Demyelinating Disease: Definitions and Overlap Overview

THE NATURAL HISTORY OF MS: DIAGNOSIS, CLINICAL COURSE, AND EPIDEMIOLOGY

PATIENT INFORMATION: Patient Surname First Name Middle Initial Sex Date of Birth Alberta Personal Health Number M / F Year Month Day

Paraparesis. Differential Diagnosis. Ran brauner, Tel Aviv university

Hot Topics Multiple Sclerosis. Natalie Parks, MD, FRCPC Assistant Professor, Dalhousie University June 27, 2018

Brainstorming the Case: An unusual presentation of autoimmune encephalitis

Research Article Optic Nerve and Spinal Cord Are the Major Lesions in Each Relapse of Japanese Multiple Sclerosis

MRI Imaging of Neuromyelitis Optica

Common Pitfalls in Multiple Sclerosis and CNS Demyelinating Diseases

Unraveling the Mystery of MS Differential Diagnosis

Brain and Central Nervous System Cancers

Autologous Hematopoietic Stem Cell Transplantation for the Treatment of Neuromyelitis Optica in Singapore

A pictorial review of neurological complications of systemic lupus erythematosus and antiphospholipid syndrome

Multiple sclerosis in Japan: Nationwide surveys over 30 years

MasterClass 4.1 Case Studies Session 1

RSR RSR RSR RSR RSR. ElisaRSR AQP4 Ab RSR. Aquaporin-4 Autoantibody Assay Kit

Multiple sclerosis mimics: Diagnostic error and management decisions

Provider Led Entity. CDI Quality Institute PLE Multiple Sclerosis (MS) AUC

Adv Pathophysiology Unit 2: Neuro Page 1 of 8

Neuromyelitis Optica Spectrum Disorder (NMOSD): Brain MRI findings in patients at our institution and literature review.

Vascular Disorders. Nervous System Disorders (Part B-1) Module 8 -Chapter 14. Cerebrovascular disease S/S 1/9/2013

Program Highlights. A multidisciplinary AAN working group identified areas for improvement in the diagnosis and management of patients with MS

Kathleen R. Fink, MD Virginia Mason Medical Center. 6 th Nordic Emergency Radiology Course 2017

Professor Yasser Metwally. Neuromyelitis optica. EPIDEMIOLOGY

Mercy MS Center New Patient Information

CNS pathology Third year medical students. Dr Heyam Awad 2018 Lecture 4: Myelin diseases of the CNS

THE NATURAL HISTORY OF MS: DIAGNOSIS, CLINICAL COURSE, AND EPIDEMIOLOGY

MULTIPLE SCLEROSIS - REVIEW AND UPDATE

PRIMARY DISEASES OF MYELIN. By: Shifaa Al Qa qa

Case presentation. Frini Karaolidou Florentia Savva Demetra Tourva Trainees in Internal Medicine, General Hospital of Limassol, Cyprus

The Role of MRI in Multiple Sclerosis

Dizziness: Neurological Aspect

NANOS Patient Brochure

Headache Assessment In Primary Eye Care

Tumefactive multiple sclerosis lesions: Diagnostic challenge for the radiologist

References 1. Feng S et al. Journal of Thoracic Oncology 2017; 12: Spain L et al. Annals of Oncology 2017; 28:

NEW DIAGNOSTIC CRITERIA FOR MULTIPLE SCLEROSIS

meninges Outermost layer of the meninge dura mater arachnoid mater pia mater membranes located between bone and soft tissue of the nervous system

Peripheral neuropathies, neuromuscular junction disorders, & CNS myelin diseases

UNDERSTANDING MULTIPLE SCLEROSIS CINDY ANDERSON MSN, APRN, ACNP, ANP, CNRN FEBRUARY 2017

Central nervous system

Epilepsy DOJ Lecture Masud Seyal, M.D., Ph.D. Department of Neurology University of California, Davis

Disclosures. Rheumatological Approaches to Differential Diagnosis, Physical Examination, and Interpretation of Studies. None

MEDIA BACKGROUNDER. Multiple Sclerosis: A serious and unpredictable neurological disease

Setting the Scene: Neuromyelitis Optica epidemiology, population variability, subgroups: relapsing/monophasic, Ab +ve/-ve, NMO/SD, treated/untreated

Endpoints in a treatment trial in NMO: Clinician s view. Anu Jacob Consultant Neurologist The Walton Centre, Liverpool,UK

Patient with Daily Headache NTERNATIONAL CLASSIFICATION HEADACHE DISORDERS. R. Allan Purdy, MD, FRCPC,FACP. Professor of Medicine (Neurology)

Chief Complaint. History. History of Similar Episodes. A 10 Year-Old Boy With Headache

Clinical Information on West Nile Virus (WNV) Infection

HEADACHES THE RED FLAGS

Multiple Sclerosis , The Patient Education Institute, Inc. nr Last reviewed: 04/17/2017 1

Contents 1 Immunology for the Non-immunologist 2 Neurology for the Non-neurologist 3 Neuroimmunology for the Non-neuroimmunologist

Neuroimaging and Other Biomarkers. MRI for Diagnosis, Prognosis and Treatment Decisions in MS

Misdiagnosed Vogt-Koyanagi-Harada (VKH) disease and atypical central serous chorioretinopathy (CSC)

P1: OTA/XYZ P2: ABC c01 BLBK231-Ginsberg December 23, :43 Printer Name: Yet to Come. Part 1. The Neurological Approach COPYRIGHTED MATERIAL

Multiple Sclerosis. Brain Spinal Cord. Peripheral Nerves

Reporting Autoimmune Diseases in Hematopoietic Stem Cell Transplantation

Overview INTRODUCTION 3/15/2018. Headache Emergencies. Other way to differentiate between them? Is there an easy way to differentiate between them?

Sawada J, Orimoto R, Misu T, Katayama T, Aizawa H, Asanome A, Takahashi K, Saito T, Anei R, Kamada K, Miyokawa N, Takahashi T, Fujihara K, Hasebe N.

Hydrocephalus 1/16/2015. Hydrocephalus. Functions of Cerebrospinal fluid (CSF) Flow of CSF

CLINICAL PRESENTATION AND RADIOLOGY QUIZ QUESTION

Neurological Assessment for Multiple Sclerosis and Extended Disability Scale Score

Neuromyelitis Optica: A Case Report

Magnetic Resonance Imaging in the Acquired Demyelinating Disorders: A Pediatric Cohort Study

Progress in MS: Current and Emerging Therapies. Presented by: Dr. Kathryn Giles, MD MSc FRCPC Cambridge, Ontario, Canada

Clinicopathological Conference

Balo s concentric lesions with concurrent features of Schilder s disease in relapsing multiple sclerosis: neuropathological findings

Alan Barber. Professor of Clinical Neurology University of Auckland

387

NIH Public Access Author Manuscript J Neurol Sci. Author manuscript; available in PMC 2010 February 24.

Transcription:

The Diagnosis Of Multiple Sclerosis DR SAHER HASHEM PROF OF NEUROLOGY CAIRO UNIVERSITY

There is no path gnomonic or perfect laboratory test which may be used in isolation to reliably diagnose MS. The key to correct diagnosis is typicality The duck test is important, ( is this a duck, it looks like a duck, walk like and quacks like a duck, then it is probably a duck. duck, and

Question One What is the most common mistake during MS diagnosis? The most common mistake during MS diagnosis is a false positive attribution that is making a diagnosis of MS in patients who don t t have MS.Often this error is the result of uncritical or causal reliance on MRI without appropriate clinical correlation

62 patients assessed by general neurologists and reassessed by other general neurologists using Mc Donald s s criteria and found 51% of MS patients were not confirmed. Mc Hugh et al Multiple sclerosis 2008,14:81-85 85

Time from initial symptom to MS diagnosis Initial symptom Time to MS diagnosis 1980-1984 1984 7 y 1985-1989 5.3 y 1990-1994 3.7 y 1995-1999 1.8y > 2000 0.63y Marie et al Neurology 2005,65;1066-1070 1070

Question 2 What is the definition and gold standards in the diagnosis of MS.? 1- Evidence of dissemination in space ( multifocality). 2- Evidence of dissemination in time ( recurrent attacks or steady progression) 3- No better explanation to account for signs and symptoms.

Clinically isolated syndromes are not MS. This could be optic neuritis,myelitis,or brain stem dysfunction CIS is not MS.this is very analogous to first attack of convulsions. CIS may or may not evolve to MS.this depends on follow up using Mc Donald's criteria (paraclinical( MRI evidence).

ACIS = Atypical clinically isolated syndrome Like parasthesias or clumsiness. Some suggested the use of early treatment in MS and some types of CIS Frahman et al Arch.neurol. 2006 ; 614-618 618

Question 3 What are the Mc Donald's criteria? The first or ground floor,without which the structure can t exist, is the clinical assessment (history,neurologic examination the goal of which is: 1-DIS (dissemination in space) 2-DIT ( dissemination in time ) 3-NBE ( no better explanation ) Schmacher et al Ann NY acad sci 1965, 12:522-568 568 Poser et al,neurosurg,2004; 106 : 147-158. 158. Mc Donalds et al, Ann Neurolog,, 2001,50: 121-127 127

Definition of MS attack according to Mc Donald's 2001: 1-Clinical event of type seen in MS. 2-Event lasts at least 24 hours. 3-Objective findings must be present. 4-The event shouldn t t be pseudo attack (temporary worsening due to fever or infection) 5-The onset should be at least 40 days after onset of previous attack. 6- Single paroxysmal attack eg muscle spasm is not countable, but multiple paroxysmal events occurring over a period of 24 hours.

A patient who presented with ON,experience a second attack one month later(dit) with bilateral INO (DIS) and there are no atypical features(nbe)

Revised (2005) Mc Donalds criteria for (DIS) and (DIT) A-DIS at least 3 of the following must be present 1-1 At least one gadolinium enhancing lesion or nine T 2 hyperintense lesions. 2-At 2 least one infratentorial lesion 3-At least one juxta cotical 4-4 At least 3 periventricular. NB one spinal lesion may be used to fulfill criteria 1+2.Spinal lesions at least 3 mm in size,less than 2 vertebral segments occupying only part of the cross section of spinal cord.csf oligoclonal bands and 2 typical MRI lesions can establish the diagnosis of MS

DIT The presence of new lesion (gadolinium enhanced) not corresponding to site implicated with initial event if the scan done 3 months after the event.

MRI Lesions similar to MS. 1-SLE 2-2 SJOGREN S 3- SARCOIDOSIS 4-ADEM4 5- ANTIPHOSPHOLIPID ANTIBODY SYND 6- LEBER OPTIC ATROPHY 7-CADASIL 8-SUSAC 8 SYNDROME 9 -USHER SYNDROME 10-VIT E DEFICIENCY 11-LYMPHOMA

SUSAC SYNDROME Was first described in 1975 sufferers often experience personality changes and bizarre and develop paranoid behavior. Speech can be affected and many experience severe headaches and migraine. Some hearing and visual loss which might correct itself in a matter of 5 years. Diagnosis MRI multifocal supratentorial lesions most lesions are small ones 3-73 7 mm which might affect grey matter and show meningeal enhancement which never found in MS NOR ADEM. Pathogenesis vasculitis,hypercoagulable,or viral infection.treatment hyperbaric o2,ivig,iv steroids

usher syndrome Is a leading cause ion is of deaf blindness is an autosomal recessive condition.the vision is described as doughnut vile vision where central and peripheral visions are spared while impaired in an annulus around central vision. Three types were described 1&2 are born with disease while 3 acquired loss of vision and hearing. Treatment gene therapy.

Question 4 What are the best clinical keys for MS diagnosis? A- Typical time course of an attack of MS.Usually the attack takes a gradual progressive course with peak at 3-43 4 weeks with gradual decline and recovery at 6 week differing from epilepsy and migraine attacks which resolves in 24 hours.

B-Typical history Using schumacher criteria 1965 involving DIT,DIS,and NBE.

C- Red flags This means negative criteria diagnosing NOT MS. 1- Neurological red flags. 2- Genetic red flags. 3- Psychiatric red flags. 4- MRI red flags.

1- Neurological red flags. Absence of eye signs like ON,or INO Absence of clinical remission. Absence of sensory finding or bladder disturbance. Localized disease in one brain region. Absence of typical CSF changes Rudik RA; et al Arch Neurology 1989;53:1698-1704. 1704.

2-Genetic red flags. Family history of MS ( first degree relative) Early age of onset ( less than 15 years old) Natawicz and Bejjani,Am.j. Genetics,1994;46 149-169 169

3- Psychiatric red flags. Marked disproportion of psychiatric symptoms relative to objective neurological signs. Prior history of major psychiatric illness Parlson GW,south med J 1969;89 ;301-304 304

4- MRI red flags ------------------------------------------------------------- MRI finding---------------------- ---------------------- Think over ------------------------------------------------------------- Brain Symmetrical lesions ---------- ADEM,or adult leukodystrophy Absent activity on ------------> > ADEM or chronic Serial scans meningitis Infarcts ------------------------ SLE,lacunes Predominant juxta------------ ------------> > small vessel disease. Cortical lesions Normal brain MRI in spite----------- ----------- Neuromyelitis optica Severe cord and optic nerve lesions

Spinal MRI ---------------- Think over More than 3 segments--- --- NMO,SS,ADEM, TS myelitis Diffuse posterior column-- -- vit B 12 def, acquired cu def Meningeal enhancement- Susac syndrome primary CNS angitis Behcet,Lymes,sarcoid

Question 5 Is the population suspected to have MS are homogenous? In fact the population suspected to have MS constitute a heterogeneous groups many of them will ultimately be found to have MS,and some of whom may have other neurological diseases which mimic MS.

Stratification of MS suspected into subgroups on basis of typicality. Group 1: finding typical of MS. MS is likely a diagnosis. Group 2: atypical with normal finding's is very unusual Group 3: atypical with minimal definite findings,ms is possible Group 4: atypical with major unusual findings, wide DD

Example of group 1 Female 18 y,presented with rt eye pain and blurring of vision she was diagnosed as ON and treated with steroids and recovered partially in one month.two y later (DIT) she developed over a period of week RT UL parasthesia and weakness with spontaneous resolution over a month (DIS) on /ex severe optic atrophy, brisk DTR RT side with bilateral subtle ataxia.mri numerous T 2 periventricular hyperintesties(nbe).disease modifying therapy was initiated (DMT) in the form of interferons.

Example of group 2 Female 28 y she underwent hysterectomy for cervical dysplasia 2 days later she developed weakness and shooting pains in her LLs. Work up was negative and she recovered completely in 6 weeks with physiotherapy. Succeeding 5 y she continued to experience transient non specific pains, mental stress,fatigue,cramps,tingling in non anatomical patterns. Her past medical history was notable for depression and fibromyalgia and bimonthly severe occipital headache which was not associated with nausea or vomiting or scintillating scotomata.assessment by her primary neurologist revealed NAD all investigations were negative apart from some white spots (punctuate) in the left cerebrum.

Example of group 3 (possible or probable MS) a male 27 y,noted electric like shocks on neck flexion, these symptoms recurred for 2 months and stopped but recurred again at the age of 33y(DIT).His past medical history showed transient left arm pain at age of 30y with notably no specific diagnosis. Significantly,his family history revealed documented MS in older sister and perhaps in mother. Comment essentially this gentleman presents with recurrent lehermitte sign and strong FH. Over the course of one decade he had no major progression this remained possible due to lack of (DIS) and lack of objective neurological signs. Finally at age of 37yhe developed sub acute sensory loss in LLs and csf was +ve and MRI was classic of MS he received pulsed steroids with good response and he started DMT

Example group 4 Atypical patient presents with major but unusual finding here other neurological disease is possible.

Question 6 What are the MS variants? 1- Neuromyelitis optica NMO 2- Tumefactive MS ( tumor like course) 3- Fulminate acute MS (Marburg) 4- Balo concentric sclerosis. 5- Myelinoclastic diffuse sclerosis(schilder disease)

NMO is considered when patient presents acutely with severe bilateral optic ON for the first time or presenting with unusually severe myelitis,mri head minimal atypical changes, spinal MRI shows longitudinal more than 3 segments extensive lesion. and CSF shows +ve monoclonal bands in 25% and +ve autoantibody NMO igg with sensitivity of 73% and 90% specificity and is directed against aquaporin water channels present on astrocytic foot process. CSF also shows granulocytic increase rather than lymphocytic increase.it has bad response to DMT.

Question 7 What is the role of lab in MS? 1- Screenining tests like MRI,cbc,ANA,vit b 12,RPR (rapid plasma reagin for syphilis) 2- CSF for oligoclonal bands.igg index and synthesis,ver,ss-a,ss A,SS- B,SER,ANCA,anticardiolipin,lyme serology,thyroid function,serum antibodies innmo,serum copper incase of unexplained myelopathy,serum long chain fatty acids,dna,for cadasil,aryl sulphatase and ACE for sarcoidosis.

Accuracy of MRI Application of MRI according Mc Donald's criteria has yielded high sensitivity of 75% and specificity of 85% for prediction of CDMS during approximately 2 years of observation for patients with CIS. ANN (2003) published guidelines for the use of MRI in diagnosis of MS. Saying that 3 characteristic white matter lesions are more sensitive predictor of CDMS in CIS patients than complex Mc Donald's criteria.

Question 8 What are major pitfalls in MS diagnosis? 1- Atypical MS : This is CDMS with some unusual features like a- Acute attacks with abrupt onset. b- Fixed relationship to menses c- Late onset d- Prominent cognitive, or psychiatric symptoms early in disease

2- Inconvenient MS. Where MS patient has only one inconvenient lab test e.g. very high ANA in the absence of rheumatologic disease, or CSF with marked pleocytosis. 3- Partial MS. These cases represent intermediate between CIS and CDMS.

THANK YOU